Celularity Inc. - stock earnings

CELU Upcoming estimated earnings

Date Actual / Estimated EPS Low Revenue Actual / Estimated Revenue High Revenue
May 27, 2024 BeforeMarket - / -0.1400000000 - - / 4.7 million -

CELU Quarterly earnings

DateEarningsRevenue
2023Q4 -93.9 million USD 3.8 million USD
2023Q3 -93.9 million USD 3.8 million USD
2023Q2 -47.9 million USD 2.9 million USD
2023Q1 -64.0 million USD 3.9 million USD
2022Q4 24.4 million USD 4.1 million USD
2022Q3 4.8 million USD 4.1 million USD
2022Q2 47.8 million USD 3.8 million USD
2022Q1 -62.9 million USD 5.9 million USD
2021Q4 -4.0 million USD 4.9 million USD
2021Q3 49.9 million USD 10.6 million USD
2021Q2 -64.5 million USD 3.2 million USD
2021Q1 -81.5 million USD 2.7 million USD
2020Q4 3.9 million USD 3.2 million USD
2020Q3 -46.3 million USD 3.4 million USD
2020Q2 -12.1 million USD 3.5 million USD
2020Q1 1.0 million USD ? USD
2019Q4 757265 USD ? USD
2019Q3 1.1 million USD ? USD
2019Q2 634660 USD ? USD
2019Q1 -121 USD ? USD

CELU Yearly earnings

DateEarningsRevenue
2023 -181.4 million USD 14.8 million USD
2022 14.2 million USD 18.0 million USD
2021 -100.1 million USD 21.3 million USD
2020 -208.2 million USD 14.3 million USD
2019 5.9 million USD 21.1 million USD
2018 -13.4 million USD 17.6 million USD

CELU

Price: $3.08

52 week price:
1.59
8.90

Earnings Per Share: -10.30 USD

P/E Ratio: -0.46

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 396900

Market Capitalization: 71.7 million

Links: